Literature DB >> 12972909

Drug abuse with inhalated xylazine.

Jose I Elejalde1, Clint Jean Louis, Rosario Elcuaz, Miguel A Pinillos.   

Abstract

Given the difficulty of obtaining traditionally illicit drugs, consumption is turning towards less restricted products. We report the case of an 18-year-old man, who after inhaling xylazine (a non-narcotic sedative used in veterinary medicine for analgesia, hypnosis and muscle relaxation) presented with an episode of chills and dizziness followed by sweating, gait instability, palpitations and two episodes of syncope with bradycardia and hypotension. Ten cases of toxicity caused by xylazine consumption by oral and parenteral administration (intramuscular, subcutaneous, and intravenous) have been documented in humans. In these cases, consumption was either involuntary or for suicidal or homicidal purposes, or used as an agent of drug abuse, occasionally resulting in death. We present the second documented case of toxic effects of drug abuse with inhalated xylazine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972909     DOI: 10.1097/00063110-200309000-00022

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  5 in total

1.  Xylazine (veterinary sedative) use in Puerto Rico.

Authors:  Rafael A Torruella
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-04-11

2.  GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.

Authors:  Nayra Rodríguez; José Vargas Vidot; Juan Panelli; Héctor Colón; Bob Ritchie; Yasuhiro Yamamura
Journal:  Drug Alcohol Depend       Date:  2008-05-09       Impact factor: 4.492

3.  Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine.

Authors:  L A Silva-Torres; C Vélez; J Lyvia Alvarez; J G Ortiz; B Zayas
Journal:  Toxicol In Vitro       Date:  2014-07-08       Impact factor: 3.500

4.  Nanocoral-like Polyaniline-Modified Graphene-Based Electrochemical Paper-Based Analytical Device for a Portable Electrochemical Sensor for Xylazine Detection.

Authors:  Kasrin Saisahas; Asamee Soleh; Kiattisak Promsuwan; Jenjira Saichanapan; Apichai Phonchai; Nabeesathul Sumayya Mohamed Sadiq; Way Koon Teoh; Kah Haw Chang; Ahmad Fahmi Lim Abdullah; Warakorn Limbut
Journal:  ACS Omega       Date:  2022-04-12

5.  Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys.

Authors:  Yong-Fu Xiao; Bingdi Wang; Xiaoli Wang; Fenglai Du; Michael Benzinou; Yi-Xin Jim Wang
Journal:  BMC Anesthesiol       Date:  2013-10-20       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.